Research at Boston Children's Hospital

The research enterprise at Boston Children’s Hospital, comprising more than 3,000 researchers, is the world’s largest at a pediatric center. Our work is fueled by a deep understanding of disease coupled with world-class discovery platforms, including genetics and genomics, gene editing, bioinformatics, proteomics, bioengineering, image analysis, multiple animal models, biobanks and disease-specific stem cell lines. We have special expertise in rare disease discovery and see large, highly diverse patient populations.

michael rogers and danielle peterse

Find a Researcher

More than 3,000 researchers & scientific staff

Find a Researcher
find a Boston Children

Research Labs

1 million square feet of research space — and growing

Find a Center or Lab
explore Boston Children

Explore Research Topics

$388 million in total research funding FY2018 — #1 NIH funding for pediatric research

Find a Topic

Boston Children's Hospital Innovation

BCH Innovation News @BCH_Innovation 9/13/2019 9:00:01 PM
Sevoflurane vs. isoflurane: Choice of #anesthesia may affect outcome in sepsis patients needing #surgery:…
BCH Innovation News @BCH_Innovation 9/13/2019 8:00:01 PM
Looping in #drugresistance and cancer relapse: Meet BORIS:
BCH Innovation News @BCH_Innovation 9/13/2019 7:00:01 PM
In @nature this week: Antibody diversity, courtesy of chromatin looping from the lab of @BostonChildrens Frederick…
BCH Innovation News @BCH_Innovation 9/13/2019 6:30:01 PM
Two inhaled #anesthetics both alter the immune system — enough to improve or worsen sepsis in a mouse model:…
BCH Innovation News @BCH_Innovation 9/13/2019 6:00:01 PM
New work from @BostonChildrens Moses Lab shows #extracellularvesicles are able to breach the drum-tight blood brain…
BCH Innovation News @BCH_Innovation 9/13/2019 5:00:00 PM
Some of the brightest minds in digital health will be taking the stage at #VoiceHLTH, don't miss it! See the full l…
Building on our extraordinary leadership in pediatric science at Boston Children’s, we translate our findings — and those of others — to fundamentally change how disease is treated and cured.

David A. Williams, MD
Senior Vice President and Chief Scientific Officer